摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4S,5R,6R)-4-azido-6-(dipropylcarbamoyl)-5-(2,2,2-trifluoroacetylamino)-5,6-dihydro-4H-pyran-2-carboxylic acid, methyl ester | 185382-36-9

中文名称
——
中文别名
——
英文名称
(4S,5R,6R)-4-azido-6-(dipropylcarbamoyl)-5-(2,2,2-trifluoroacetylamino)-5,6-dihydro-4H-pyran-2-carboxylic acid, methyl ester
英文别名
methyl (2R,3R,4S)-4-azido-2-(dipropylcarbamoyl)-3-[(2,2,2-trifluoroacetyl)amino]-3,4-dihydro-2H-pyran-6-carboxylate
(4S,5R,6R)-4-azido-6-(dipropylcarbamoyl)-5-(2,2,2-trifluoroacetylamino)-5,6-dihydro-4H-pyran-2-carboxylic acid, methyl ester化学式
CAS
185382-36-9
化学式
C16H22F3N5O5
mdl
——
分子量
421.376
InChiKey
HKGVLKNBZIIWPA-MVWJERBFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    29
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    99.3
  • 氢给体数:
    1
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 6-Carboxamido dihydropyran derivatives
    申请人:Biota Scientific Management PTY Ltd.
    公开号:US05990156A1
    公开(公告)日:1999-11-23
    Compounds of formula (I), ##STR1## wherein R.sup.1 represents OR.sup.5, SR.sup.5, NR.sup.5 R.sup.6, N(OR.sup.5)R.sup.6 or N(NR.sup.5 R.sup.6)R.sup.6 ; X represents OH, N.sub.3, NR.sup.3 R.sup.4 or NR.sup.4 CO.sub.2 R.sup.15 ; Y represents H or NHR.sup.2 ; R.sup.2 represents a group SO.sub.2 R.sup.7 or COR.sup.7 ; R.sup.3 represents H, C.sub.1-6 alkyl or C(.dbd.NR.sup.8)NR.sup.9 R.sup.10 ; R.sup.4 represents H or C.sub.1-6 alkyl; R.sup.5 represents H, C.sub.1-20 alkyl, C.sub.3-8 cycloalkyl, C.sub.2-20 alkenyl, C.sub.2-20 alkynyl, CHR.sup.11 COR.sup.12 or C.sub.1-20 alkyl substituted by one or more groups selected from NR.sup.13 R.sup.14, NR.sup.13 COR.sup.14, CO.sub.2 R.sup.13, OR.sup.13, C.sub.3-8 cycloalkyl and optionally substituted aryl; each R.sup.6 independently represents H, C.sub.1-6 alkyl, C.sub.3-8 cycloalkyl, C.sub.2-6 alkenyl, C.sub.2-20 alkynyl, aryl or C.sub.1-4 alkyl substituted by one or more groups selected from NR.sup.13 R.sup.14, COR.sup.13, C.sub.3-8 cycloalkyl, CN, N.sub.3, OR.sup.13 and optionally substituted aryl; or R.sup.5 and R.sup.6 together form a C.sub.2-6 hydrocarbon chain which may optionally contain a group NR.sup.13 which chain is optionally substituted by 1, 2, 3 or 4 groups selected from oxo and C.sub.1-6 alkyl groups which groups may optionally be substituted by hydroxy or optionally substituted aryl; R.sup.7 represents C.sub.1-6 alkyl optionally substituted by one or more halogen atoms, C.sub.3-8 cycloalkyl or optionally substituted aryl; R.sup.8, R.sup.9 and R.sup.10 each independently represent H, C.sub.1-6 alkyl, amino, hydroxy, cyano or nitro; R.sup.11 represents the side chain of a D- or L-amino acid; R.sup.12 represents NR.sup.13 R.sup.14, OR.sup.13 or R.sup.13 ; each R.sup.13 and each R.sup.14 independently represents H, C.sub.1-6 alkyl or optionally substituted arylC.sub.1-4 alkyl; R.sup.15 represents C.sub.1-6 alkyl; and their pharmaceutically acceptable derivatives are neuraminidase inhibitors useful in the treatment of viral infections.
    式(I)的化合物,其中R.sup.1代表OR.sup.5,SR.sup.5,NR.sup.5 R.sup.6,N(OR.sup.5)R.sup.6或N(NR.sup.5 R.sup.6)R.sup.6; X代表OH,N.sub.3,NR.sup.3 R.sup.4或NR.sup.4 CO.sub.2 R.sup.15; Y代表H或NHR.sup.2; R.sup.2代表SO.sub.2 R.sup.7或COR.sup.7基团; R.sup.3代表H,C.sub.1-6烷基或C(.dbd.NR.sup.8)NR.sup.9 R.sup.10; R.sup.4代表H或C.sub.1-6烷基; R.sup.5代表H,C.sub.1-20烷基,C.sub.3-8环烷基,C.sub.2-20烯基,C.sub.2-20炔基,CHR.sup.11 COR.sup.12或C.sub.1-20烷基,其上取代着一个或多个选自NR.sup.13 R.sup.14,NR.sup.13 COR.sup.14,CO.sub.2 R.sup.13,OR.sup.13,C.sub.3-8环烷基和可选取代的芳基的基团; 每个R.sup.6独立地代表H,C.sub.1-6烷基,C.sub.3-8环烷基,C.sub.2-6烯基,C.sub.2-20炔基,芳基或C.sub.1-4烷基,其上取代着一个或多个选自NR.sup.13 R.sup.14,COR.sup.13,C.sub.3-8环烷基,CN,N.sub.3,OR.sup.13和可选取代的芳基的基团; 或R.sup.5和R.sup.6共同形成一个C.sub.2-6烃链,该链可以选择性地含有一个NR.sup.13基团,该链可以取代1、2、3或4个选自氧代和C.sub.1-6烷基基团的基团,这些基团可以选择性地被羟基或可选取代的芳基取代; R.sup.7代表C.sub.1-6烷基,其上可以选择性地取代一个或多个卤素原子,C.sub.3-8环烷基或可选取代的芳基; R.sup.8,R.sup.9和R.sup.10各自独立地表示H,C.sub.1-6烷基,氨基,羟基,氰基或硝基; R.sup.11表示D-或L-氨基酸的侧链; R.sup.12表示NR.sup.13 R.sup.14,OR.sup.13或R.sup.13; 每个R.sup.13和每个R.sup.14独立地表示H,C.sub.1-6烷基或可选取代的芳基C.sub.1-4烷基; R.sup.15表示C.sub.1-6烷基; 它们的药学上可接受的衍生物是神经氨酸酶抑制剂,用于治疗病毒感染。
  • Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides
    作者:Paul G Wyatt、Barry A Coomber、Derek N Evans、Torquil I Jack、Heather E Fulton、Alan J Wonacott、Peter Colman、Jose Varghese
    DOI:10.1016/s0960-894x(01)00019-1
    日期:2001.3
    SAR investigations of the 4- and 5-positions of a series of 4-amino-4H-pyran-2-carboxylic acid 6-carboxamides are reported. Potent inhibitors of influenza A sialidase with marked selectivity over the influenza B enzyme were obtained when the basic 4-amino substituent was replaced by hydroxyl or even deleted. Modifications at the 5-position exhibited a tight steric requirement, with trifluoroacetamide being optimal. (C) 2001 Elsevier Science Ltd. All rights reserved.
查看更多